(230401, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001627', 'abnormal cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230402, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230403, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230404, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230405, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230406, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010510', 'absent P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230407, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0020345', 'abnormal myocardial fiber currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230408, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010392', 'prolonged QRS complex duration', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230409, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004878', 'increased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230410, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230411, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230412, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011919', 'abnormal R wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230413, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230414, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230415, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230416, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230417, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230418, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003823', 'increased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230419, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230420, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230421, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230422, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230423, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230424, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0013134', 'poor circulation in autopods', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230425, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230426, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010515', 'abnormal Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230427, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230428, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230429, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010519', 'atrioventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230430, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010520', 'sinoatrial block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230431, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230432, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012046', 'decreased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230433, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031128', 'cardiovascular shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230434, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003900', 'shortened QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230435, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230436, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0006266', 'decreased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230437, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230438, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230439, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230440, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230441, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230442, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230443, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031170', 'abnormal vasculature physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230444, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230445, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230446, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230447, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230448, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230449, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004879', 'decreased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230450, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011952', 'decreased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230451, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0005333', 'decreased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230452, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230453, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230454, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003547', 'abnormal pulmonary pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230455, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230456, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230457, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230458, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230459, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001596', 'hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230460, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003038', 'decreased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230461, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230462, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003548', 'pulmonary hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230463, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230464, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010504', 'abnormal RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230465, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230466, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002128', 'abnormal blood circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230467, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230468, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003438', 'abnormal carotid body physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230469, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230470, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230471, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230472, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230473, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230474, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230475, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230476, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230477, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0006111', 'abnormal coronary circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230478, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0006138', 'congestive heart failure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230479, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011951', 'increased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230480, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230481, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010695', 'abnormal blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230482, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004086', 'absent heartbeat', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230483, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004485', 'increased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230484, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230485, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004072', 'abnormal frontal plane axis', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230486, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011928', 'abnormal mitral valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230487, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001914', 'hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230488, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011920', 'abnormal S wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230489, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230490, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230491, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011938', 'prolonged PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230492, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011954', 'shortened PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230493, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011937', 'shortened PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230494, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031152', 'subcutaneous hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230495, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230496, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230497, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230498, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230499, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230500, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010511', 'shortened PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230501, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0008776', 'increased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230502, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230503, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010507', 'shortened RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230504, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031129', 'left-to-right shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230505, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010394', 'decreased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230506, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000249', 'abnormal blood vessel physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230507, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230508, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230509, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230510, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230511, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230512, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230513, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230514, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230515, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230516, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010553', 'prolonged HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230517, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230518, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002626', 'increased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230519, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230520, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0013135', 'poor circulation in tail', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230521, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230522, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230523, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230524, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230525, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0011953', 'prolonged PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230526, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004217', 'salt-sensitive hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230527, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0000233', 'abnormal blood flow velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230528, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010634', 'increased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230529, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0010636', 'bundle branch block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230530, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230531, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230532, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0003549', 'pulmonary hypotension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230533, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230534, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0013127', 'epistaxis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230535, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230536, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230537, 'HP:0005147', 'Bidirectional ventricular ectopy', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230538, 'HP:0010872', 'T-wave inversion', 'MP:0011928', 'abnormal mitral valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230539, 'HP:0010872', 'T-wave inversion', 'MP:0011937', 'shortened PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230540, 'HP:0010872', 'T-wave inversion', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230541, 'HP:0010872', 'T-wave inversion', 'MP:0001914', 'hemorrhage', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230542, 'HP:0010872', 'T-wave inversion', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230543, 'HP:0010872', 'T-wave inversion', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230544, 'HP:0010872', 'T-wave inversion', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230545, 'HP:0010872', 'T-wave inversion', 'MP:0003928', 'increased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230546, 'HP:0010872', 'T-wave inversion', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230547, 'HP:0010872', 'T-wave inversion', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230548, 'HP:0010872', 'T-wave inversion', 'MP:0005330', 'cardiomyopathy', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230549, 'HP:0010872', 'T-wave inversion', 'MP:0001636', 'irregular heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230550, 'HP:0010872', 'T-wave inversion', 'MP:0004216', 'salt-resistant hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230551, 'HP:0010872', 'T-wave inversion', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230552, 'HP:0010872', 'T-wave inversion', 'MP:0004879', 'decreased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230553, 'HP:0010872', 'T-wave inversion', 'MP:0010631', 'increased Q wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230554, 'HP:0010872', 'T-wave inversion', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230555, 'HP:0010872', 'T-wave inversion', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230556, 'HP:0010872', 'T-wave inversion', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230557, 'HP:0010872', 'T-wave inversion', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230558, 'HP:0010872', 'T-wave inversion', 'MP:0010393', 'shortened QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230559, 'HP:0010872', 'T-wave inversion', 'MP:0010570', 'prolonged ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230560, 'HP:0010872', 'T-wave inversion', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230561, 'HP:0010872', 'T-wave inversion', 'MP:0006044', 'tricuspid valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230562, 'HP:0010872', 'T-wave inversion', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230563, 'HP:0010872', 'T-wave inversion', 'MP:0020418', 'increased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230564, 'HP:0010872', 'T-wave inversion', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230565, 'HP:0010872', 'T-wave inversion', 'MP:0003898', 'abnormal QRS complex', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230566, 'HP:0010872', 'T-wave inversion', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230567, 'HP:0010872', 'T-wave inversion', 'MP:0011952', 'decreased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230568, 'HP:0010872', 'T-wave inversion', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230569, 'HP:0010872', 'T-wave inversion', 'MP:0003233', 'prolonged QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230570, 'HP:0010872', 'T-wave inversion', 'MP:0006266', 'decreased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230571, 'HP:0010872', 'T-wave inversion', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230572, 'HP:0010872', 'T-wave inversion', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230573, 'HP:0010872', 'T-wave inversion', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230574, 'HP:0010872', 'T-wave inversion', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230575, 'HP:0010872', 'T-wave inversion', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230576, 'HP:0010872', 'T-wave inversion', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230577, 'HP:0010872', 'T-wave inversion', 'MP:0011927', 'abnormal cardiac valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230578, 'HP:0010872', 'T-wave inversion', 'MP:0000233', 'abnormal blood flow velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230579, 'HP:0010872', 'T-wave inversion', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230580, 'HP:0010872', 'T-wave inversion', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230581, 'HP:0010872', 'T-wave inversion', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230582, 'HP:0010872', 'T-wave inversion', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230583, 'HP:0010872', 'T-wave inversion', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230584, 'HP:0010872', 'T-wave inversion', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230585, 'HP:0010872', 'T-wave inversion', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230586, 'HP:0010872', 'T-wave inversion', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230587, 'HP:0010872', 'T-wave inversion', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230588, 'HP:0010872', 'T-wave inversion', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230589, 'HP:0010872', 'T-wave inversion', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230590, 'HP:0010872', 'T-wave inversion', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230591, 'HP:0010872', 'T-wave inversion', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230592, 'HP:0010872', 'T-wave inversion', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230593, 'HP:0010872', 'T-wave inversion', 'MP:0009275', 'bruising', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230594, 'HP:0010872', 'T-wave inversion', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230595, 'HP:0010872', 'T-wave inversion', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230596, 'HP:0010872', 'T-wave inversion', 'MP:0010392', 'prolonged QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230597, 'HP:0010872', 'T-wave inversion', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230598, 'HP:0010872', 'T-wave inversion', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230599, 'HP:0010872', 'T-wave inversion', 'MP:0004217', 'salt-sensitive hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230600, 'HP:0010872', 'T-wave inversion', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230601, 'HP:0010872', 'T-wave inversion', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230602, 'HP:0010872', 'T-wave inversion', 'MP:0009698', 'heart hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230603, 'HP:0010872', 'T-wave inversion', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230604, 'HP:0010872', 'T-wave inversion', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230605, 'HP:0010872', 'T-wave inversion', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230606, 'HP:0010872', 'T-wave inversion', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230607, 'HP:0010872', 'T-wave inversion', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230608, 'HP:0010872', 'T-wave inversion', 'MP:0005600', 'increased ventricle muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230609, 'HP:0010872', 'T-wave inversion', 'MP:0008817', 'hematoma', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230610, 'HP:0010872', 'T-wave inversion', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230611, 'HP:0010872', 'T-wave inversion', 'MP:0008950', 'ventricular tachycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230612, 'HP:0010872', 'T-wave inversion', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230613, 'HP:0010872', 'T-wave inversion', 'MP:0010571', 'shortened ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230614, 'HP:0010872', 'T-wave inversion', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230615, 'HP:0010872', 'T-wave inversion', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230616, 'HP:0010872', 'T-wave inversion', 'MP:0010514', 'fragmented QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230617, 'HP:0010872', 'T-wave inversion', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230618, 'HP:0010872', 'T-wave inversion', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230619, 'HP:0010872', 'T-wave inversion', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230620, 'HP:0010872', 'T-wave inversion', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230621, 'HP:0010872', 'T-wave inversion', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230622, 'HP:0010872', 'T-wave inversion', 'MP:0006138', 'congestive heart failure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230623, 'HP:0010872', 'T-wave inversion', 'MP:0003394', 'increased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230624, 'HP:0010872', 'T-wave inversion', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230625, 'HP:0010872', 'T-wave inversion', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230626, 'HP:0010872', 'T-wave inversion', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230627, 'HP:0010872', 'T-wave inversion', 'MP:0008776', 'increased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230628, 'HP:0010872', 'T-wave inversion', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230629, 'HP:0010872', 'T-wave inversion', 'MP:0011918', 'abnormal PQ interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230630, 'HP:0010872', 'T-wave inversion', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230631, 'HP:0010872', 'T-wave inversion', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230632, 'HP:0010872', 'T-wave inversion', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230633, 'HP:0010872', 'T-wave inversion', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230634, 'HP:0010872', 'T-wave inversion', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230635, 'HP:0010872', 'T-wave inversion', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230636, 'HP:0010872', 'T-wave inversion', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230637, 'HP:0010872', 'T-wave inversion', 'MP:0001599', 'abnormal blood volume', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230638, 'HP:0010872', 'T-wave inversion', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230639, 'HP:0010872', 'T-wave inversion', 'MP:0003899', 'abnormal QT interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230640, 'HP:0010872', 'T-wave inversion', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230641, 'HP:0010872', 'T-wave inversion', 'MP:0004085', 'abnormal heartbeat', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230642, 'HP:0010872', 'T-wave inversion', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230643, 'HP:0010872', 'T-wave inversion', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230644, 'HP:0010872', 'T-wave inversion', 'MP:0003897', 'abnormal ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230645, 'HP:0010872', 'T-wave inversion', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230646, 'HP:0010872', 'T-wave inversion', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230647, 'HP:0010872', 'T-wave inversion', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230648, 'HP:0010872', 'T-wave inversion', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230649, 'HP:0010872', 'T-wave inversion', 'MP:0003823', 'increased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230650, 'HP:0010872', 'T-wave inversion', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230651, 'HP:0010872', 'T-wave inversion', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230652, 'HP:0010872', 'T-wave inversion', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230653, 'HP:0010872', 'T-wave inversion', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230654, 'HP:0010872', 'T-wave inversion', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230655, 'HP:0010872', 'T-wave inversion', 'MP:0011929', 'abnormal aortic valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230656, 'HP:0010872', 'T-wave inversion', 'MP:0005532', 'abnormal vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230657, 'HP:0010872', 'T-wave inversion', 'MP:0000249', 'abnormal blood vessel physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230658, 'HP:0010872', 'T-wave inversion', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230659, 'HP:0010872', 'T-wave inversion', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230660, 'HP:0010872', 'T-wave inversion', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230661, 'HP:0010872', 'T-wave inversion', 'MP:0031128', 'cardiovascular shunt', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230662, 'HP:0010872', 'T-wave inversion', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230663, 'HP:0010872', 'T-wave inversion', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230664, 'HP:0010872', 'T-wave inversion', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230665, 'HP:0010872', 'T-wave inversion', 'MP:0010506', 'prolonged RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230666, 'HP:0010872', 'T-wave inversion', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230667, 'HP:0010872', 'T-wave inversion', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230668, 'HP:0010872', 'T-wave inversion', 'MP:0006109', 'fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230669, 'HP:0010872', 'T-wave inversion', 'MP:0006045', 'mitral valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230670, 'HP:0010872', 'T-wave inversion', 'MP:0004486', 'decreased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230671, 'HP:0010872', 'T-wave inversion', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230672, 'HP:0010872', 'T-wave inversion', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230673, 'HP:0010872', 'T-wave inversion', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230674, 'HP:0010872', 'T-wave inversion', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230675, 'HP:0010872', 'T-wave inversion', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230676, 'HP:0010872', 'T-wave inversion', 'MP:0004071', 'prolonged P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230677, 'HP:0010872', 'T-wave inversion', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230678, 'HP:0010872', 'T-wave inversion', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230679, 'HP:0010872', 'T-wave inversion', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230680, 'HP:0010872', 'T-wave inversion', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230681, 'HP:0010872', 'T-wave inversion', 'MP:0001633', 'poor circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230682, 'HP:0010872', 'T-wave inversion', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230683, 'HP:0010872', 'T-wave inversion', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230684, 'HP:0010872', 'T-wave inversion', 'MP:0010695', 'abnormal blood pressure regulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230685, 'HP:0010872', 'T-wave inversion', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230686, 'HP:0010872', 'T-wave inversion', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230687, 'HP:0010872', 'T-wave inversion', 'MP:0004120', 'cardiac ischemia', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230688, 'HP:0010872', 'T-wave inversion', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230689, 'HP:0010872', 'T-wave inversion', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230690, 'HP:0010872', 'T-wave inversion', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230691, 'HP:0010872', 'T-wave inversion', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230692, 'HP:0010872', 'T-wave inversion', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230693, 'HP:0010872', 'T-wave inversion', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230694, 'HP:0010872', 'T-wave inversion', 'MP:0003901', 'abnormal PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230695, 'HP:0010872', 'T-wave inversion', 'MP:0004013', 'decreased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230696, 'HP:0010872', 'T-wave inversion', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230697, 'HP:0010872', 'T-wave inversion', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230698, 'HP:0010872', 'T-wave inversion', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230699, 'HP:0010872', 'T-wave inversion', 'MP:0020096', 'high mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230700, 'HP:0010872', 'T-wave inversion', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230701, 'HP:0010872', 'T-wave inversion', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230702, 'HP:0010872', 'T-wave inversion', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230703, 'HP:0010872', 'T-wave inversion', 'MP:0005140', 'decreased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230704, 'HP:0010872', 'T-wave inversion', 'MP:0006112', 'angina', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230705, 'HP:0010872', 'T-wave inversion', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230706, 'HP:0010872', 'T-wave inversion', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230707, 'HP:0010872', 'T-wave inversion', 'MP:0004010', 'increased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230708, 'HP:0010872', 'T-wave inversion', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230709, 'HP:0010872', 'T-wave inversion', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230710, 'HP:0010872', 'T-wave inversion', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230711, 'HP:0010872', 'T-wave inversion', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230712, 'HP:0010872', 'T-wave inversion', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230713, 'HP:0010872', 'T-wave inversion', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230714, 'HP:0010872', 'T-wave inversion', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230715, 'HP:0010872', 'T-wave inversion', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230716, 'HP:0010872', 'T-wave inversion', 'MP:0031170', 'abnormal vasculature physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230717, 'HP:0010872', 'T-wave inversion', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230718, 'HP:0010872', 'T-wave inversion', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230719, 'HP:0010872', 'T-wave inversion', 'MP:0004072', 'abnormal frontal plane axis', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230720, 'HP:0010872', 'T-wave inversion', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230721, 'HP:0010872', 'T-wave inversion', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230722, 'HP:0010872', 'T-wave inversion', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230723, 'HP:0010872', 'T-wave inversion', 'MP:0001634', 'internal hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230724, 'HP:0010872', 'T-wave inversion', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230725, 'HP:0010872', 'T-wave inversion', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230726, 'HP:0010872', 'T-wave inversion', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230727, 'HP:0010872', 'T-wave inversion', 'MP:0005435', 'hemoperitoneum', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230728, 'HP:0010872', 'T-wave inversion', 'MP:0013135', 'poor circulation in tail', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230729, 'HP:0010872', 'T-wave inversion', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230730, 'HP:0010872', 'T-wave inversion', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230731, 'HP:0010872', 'T-wave inversion', 'MP:0011953', 'prolonged PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230732, 'HP:0010872', 'T-wave inversion', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230733, 'HP:0010872', 'T-wave inversion', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230734, 'HP:0010872', 'T-wave inversion', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230735, 'HP:0010872', 'T-wave inversion', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230736, 'HP:0010872', 'T-wave inversion', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230737, 'HP:0010872', 'T-wave inversion', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230738, 'HP:0010872', 'T-wave inversion', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230739, 'HP:0010872', 'T-wave inversion', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230740, 'HP:0010872', 'T-wave inversion', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230741, 'HP:0010872', 'T-wave inversion', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230742, 'HP:0010872', 'T-wave inversion', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230743, 'HP:0010872', 'T-wave inversion', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230744, 'HP:0010872', 'T-wave inversion', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230745, 'HP:0010872', 'T-wave inversion', 'MP:0006048', 'pulmonary valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230746, 'HP:0010872', 'T-wave inversion', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230747, 'HP:0010872', 'T-wave inversion', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230748, 'HP:0010872', 'T-wave inversion', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230749, 'HP:0010872', 'T-wave inversion', 'MP:0010511', 'shortened PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230750, 'HP:0010872', 'T-wave inversion', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230751, 'HP:0010872', 'T-wave inversion', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230752, 'HP:0010872', 'T-wave inversion', 'MP:0013134', 'poor circulation in autopods', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230753, 'HP:0010872', 'T-wave inversion', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230754, 'HP:0010872', 'T-wave inversion', 'MP:0011954', 'shortened PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230755, 'HP:0010872', 'T-wave inversion', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230756, 'HP:0010872', 'T-wave inversion', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230757, 'HP:0010872', 'T-wave inversion', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230758, 'HP:0010872', 'T-wave inversion', 'MP:0003393', 'decreased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230759, 'HP:0010872', 'T-wave inversion', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230760, 'HP:0010872', 'T-wave inversion', 'MP:0003038', 'decreased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230761, 'HP:0010872', 'T-wave inversion', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230762, 'HP:0010872', 'T-wave inversion', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230763, 'HP:0010872', 'T-wave inversion', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230764, 'HP:0010872', 'T-wave inversion', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230765, 'HP:0010872', 'T-wave inversion', 'MP:0003900', 'shortened QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230766, 'HP:0010872', 'T-wave inversion', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230767, 'HP:0010872', 'T-wave inversion', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230768, 'HP:0010872', 'T-wave inversion', 'MP:0010559', 'heart block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230769, 'HP:0010872', 'T-wave inversion', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230770, 'HP:0010872', 'T-wave inversion', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230771, 'HP:0010872', 'T-wave inversion', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230772, 'HP:0010872', 'T-wave inversion', 'MP:0006047', 'aortic valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230773, 'HP:0010872', 'T-wave inversion', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230774, 'HP:0010872', 'T-wave inversion', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230775, 'HP:0010872', 'T-wave inversion', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230776, 'HP:0010872', 'T-wave inversion', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230777, 'HP:0010872', 'T-wave inversion', 'MP:0000231', 'hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230778, 'HP:0010872', 'T-wave inversion', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230779, 'HP:0010872', 'T-wave inversion', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230780, 'HP:0010872', 'T-wave inversion', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230781, 'HP:0010872', 'T-wave inversion', 'MP:0011936', 'abnormal PP interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230782, 'HP:0010872', 'T-wave inversion', 'MP:0031130', 'right-to-left shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230783, 'HP:0010872', 'T-wave inversion', 'MP:0003548', 'pulmonary hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230784, 'HP:0010872', 'T-wave inversion', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230785, 'HP:0010872', 'T-wave inversion', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230786, 'HP:0010872', 'T-wave inversion', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230787, 'HP:0010872', 'T-wave inversion', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230788, 'HP:0010872', 'T-wave inversion', 'MP:0002952', 'ventricular cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230789, 'HP:0010872', 'T-wave inversion', 'MP:0009732', 'ventricular premature beat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230790, 'HP:0010872', 'T-wave inversion', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230791, 'HP:0010872', 'T-wave inversion', 'MP:0001596', 'hypotension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230792, 'HP:0010872', 'T-wave inversion', 'MP:0011514', 'skin hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230793, 'HP:0010872', 'T-wave inversion', 'MP:0010509', 'decreased P wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230794, 'HP:0010872', 'T-wave inversion', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230795, 'HP:0010872', 'T-wave inversion', 'MP:0020097', 'low mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230796, 'HP:0010872', 'T-wave inversion', 'MP:0002626', 'increased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230797, 'HP:0010872', 'T-wave inversion', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230798, 'HP:0010872', 'T-wave inversion', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230799, 'HP:0010872', 'T-wave inversion', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230800, 'HP:0010872', 'T-wave inversion', 'MP:0003549', 'pulmonary hypotension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230801, 'HP:0010872', 'T-wave inversion', 'MP:0011951', 'increased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230802, 'HP:0010872', 'T-wave inversion', 'MP:0003547', 'abnormal pulmonary pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230803, 'HP:0010872', 'T-wave inversion', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230804, 'HP:0010872', 'T-wave inversion', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230805, 'HP:0010872', 'T-wave inversion', 'MP:0004485', 'increased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230806, 'HP:0010872', 'T-wave inversion', 'MP:0010637', 'sinus bradycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230807, 'HP:0010872', 'T-wave inversion', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230808, 'HP:0010872', 'T-wave inversion', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230809, 'HP:0010872', 'T-wave inversion', 'MP:0003824', 'decreased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230810, 'HP:0010872', 'T-wave inversion', 'MP:0010553', 'prolonged HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230811, 'HP:0010872', 'T-wave inversion', 'MP:0001627', 'abnormal cardiac output', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230812, 'HP:0010872', 'T-wave inversion', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230813, 'HP:0010872', 'T-wave inversion', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230814, 'HP:0010872', 'T-wave inversion', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230815, 'HP:0010872', 'T-wave inversion', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230816, 'HP:0010872', 'T-wave inversion', 'MP:0010504', 'abnormal RR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230817, 'HP:0010872', 'T-wave inversion', 'MP:0010634', 'increased QRS amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230818, 'HP:0010872', 'T-wave inversion', 'MP:0031153', 'stomach hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230819, 'HP:0010872', 'T-wave inversion', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230820, 'HP:0010872', 'T-wave inversion', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230821, 'HP:0010872', 'T-wave inversion', 'MP:0006265', 'increased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230822, 'HP:0010872', 'T-wave inversion', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230823, 'HP:0010872', 'T-wave inversion', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230824, 'HP:0010872', 'T-wave inversion', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230825, 'HP:0010872', 'T-wave inversion', 'MP:0010505', 'abnormal T wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230826, 'HP:0010872', 'T-wave inversion', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230827, 'HP:0010872', 'T-wave inversion', 'MP:0010520', 'sinoatrial block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230828, 'HP:0010872', 'T-wave inversion', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230829, 'HP:0010872', 'T-wave inversion', 'MP:0003882', 'abnormal pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230830, 'HP:0010872', 'T-wave inversion', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230831, 'HP:0010872', 'T-wave inversion', 'MP:0001629', 'abnormal heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230832, 'HP:0010872', 'T-wave inversion', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230833, 'HP:0010872', 'T-wave inversion', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230834, 'HP:0010872', 'T-wave inversion', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230835, 'HP:0010872', 'T-wave inversion', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230836, 'HP:0010872', 'T-wave inversion', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230837, 'HP:0010872', 'T-wave inversion', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230838, 'HP:0010872', 'T-wave inversion', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230839, 'HP:0010872', 'T-wave inversion', 'MP:0004086', 'absent heartbeat', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230840, 'HP:0010872', 'T-wave inversion', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230841, 'HP:0010872', 'T-wave inversion', 'MP:0010636', 'bundle branch block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230842, 'HP:0010872', 'T-wave inversion', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230843, 'HP:0010872', 'T-wave inversion', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230844, 'HP:0010872', 'T-wave inversion', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230845, 'HP:0010872', 'T-wave inversion', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230846, 'HP:0010872', 'T-wave inversion', 'MP:0031152', 'subcutaneous hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230847, 'HP:0010872', 'T-wave inversion', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230848, 'HP:0010872', 'T-wave inversion', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230849, 'HP:0010872', 'T-wave inversion', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230850, 'HP:0010872', 'T-wave inversion', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230851, 'HP:0010872', 'T-wave inversion', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230852, 'HP:0010872', 'T-wave inversion', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230853, 'HP:0010872', 'T-wave inversion', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230854, 'HP:0010872', 'T-wave inversion', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230855, 'HP:0010872', 'T-wave inversion', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230856, 'HP:0010872', 'T-wave inversion', 'MP:0003438', 'abnormal carotid body physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230857, 'HP:0010872', 'T-wave inversion', 'MP:0006114', 'cardiac murmur', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230858, 'HP:0010872', 'T-wave inversion', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230859, 'HP:0010872', 'T-wave inversion', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230860, 'HP:0010872', 'T-wave inversion', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230861, 'HP:0010872', 'T-wave inversion', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230862, 'HP:0010872', 'T-wave inversion', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230863, 'HP:0010872', 'T-wave inversion', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230864, 'HP:0010872', 'T-wave inversion', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230865, 'HP:0010872', 'T-wave inversion', 'MP:0002128', 'abnormal blood circulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230866, 'HP:0010872', 'T-wave inversion', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230867, 'HP:0010872', 'T-wave inversion', 'MP:0004122', 'abnormal sinus arrhythmia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230868, 'HP:0010872', 'T-wave inversion', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230869, 'HP:0010872', 'T-wave inversion', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230870, 'HP:0010872', 'T-wave inversion', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230871, 'HP:0010872', 'T-wave inversion', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230872, 'HP:0010872', 'T-wave inversion', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230873, 'HP:0010872', 'T-wave inversion', 'MP:0010516', 'absent Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230874, 'HP:0010872', 'T-wave inversion', 'MP:0010519', 'atrioventricular block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230875, 'HP:0010872', 'T-wave inversion', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230876, 'HP:0010872', 'T-wave inversion', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230877, 'HP:0010872', 'T-wave inversion', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230878, 'HP:0010872', 'T-wave inversion', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230879, 'HP:0010872', 'T-wave inversion', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230880, 'HP:0010872', 'T-wave inversion', 'MP:0004012', 'increased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230881, 'HP:0010872', 'T-wave inversion', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230882, 'HP:0010872', 'T-wave inversion', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230883, 'HP:0010872', 'T-wave inversion', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230884, 'HP:0010872', 'T-wave inversion', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230885, 'HP:0010872', 'T-wave inversion', 'MP:0004011', 'decreased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230886, 'HP:0010872', 'T-wave inversion', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230887, 'HP:0010872', 'T-wave inversion', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230888, 'HP:0010872', 'T-wave inversion', 'MP:0031129', 'left-to-right shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230889, 'HP:0010872', 'T-wave inversion', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230890, 'HP:0010872', 'T-wave inversion', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230891, 'HP:0010872', 'T-wave inversion', 'MP:0010554', 'shortened HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230892, 'HP:0010872', 'T-wave inversion', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230893, 'HP:0010872', 'T-wave inversion', 'MP:0004245', 'genital hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230894, 'HP:0010872', 'T-wave inversion', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230895, 'HP:0010872', 'T-wave inversion', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230896, 'HP:0010872', 'T-wave inversion', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230897, 'HP:0010872', 'T-wave inversion', 'MP:0004070', 'abnormal P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230898, 'HP:0010872', 'T-wave inversion', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230899, 'HP:0010872', 'T-wave inversion', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230900, 'HP:0010872', 'T-wave inversion', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230901, 'HP:0010872', 'T-wave inversion', 'MP:0010552', 'abnormal HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230902, 'HP:0010872', 'T-wave inversion', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230903, 'HP:0010872', 'T-wave inversion', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230904, 'HP:0010872', 'T-wave inversion', 'MP:0005599', 'increased cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230905, 'HP:0010872', 'T-wave inversion', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230906, 'HP:0010872', 'T-wave inversion', 'MP:0005333', 'decreased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230907, 'HP:0010872', 'T-wave inversion', 'MP:0010510', 'absent P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230908, 'HP:0010872', 'T-wave inversion', 'MP:0006049', 'semilunar valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230909, 'HP:0010872', 'T-wave inversion', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230910, 'HP:0010872', 'T-wave inversion', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230911, 'HP:0010872', 'T-wave inversion', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230912, 'HP:0010872', 'T-wave inversion', 'MP:0000465', 'gastrointestinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230913, 'HP:0010872', 'T-wave inversion', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230914, 'HP:0010872', 'T-wave inversion', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230915, 'HP:0010872', 'T-wave inversion', 'MP:0011938', 'prolonged PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230916, 'HP:0010872', 'T-wave inversion', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230917, 'HP:0010872', 'T-wave inversion', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230918, 'HP:0010872', 'T-wave inversion', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230919, 'HP:0010872', 'T-wave inversion', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230920, 'HP:0010872', 'T-wave inversion', 'MP:0013127', 'epistaxis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230921, 'HP:0010872', 'T-wave inversion', 'MP:0004156', 'abnormal QT variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230922, 'HP:0010872', 'T-wave inversion', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230923, 'HP:0010872', 'T-wave inversion', 'MP:0009384', 'cardiac valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230924, 'HP:0010872', 'T-wave inversion', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230925, 'HP:0010872', 'T-wave inversion', 'MP:0010513', 'abnormal ventricular activation time', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230926, 'HP:0010872', 'T-wave inversion', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230927, 'HP:0010872', 'T-wave inversion', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230928, 'HP:0010872', 'T-wave inversion', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230929, 'HP:0010872', 'T-wave inversion', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230930, 'HP:0010872', 'T-wave inversion', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230931, 'HP:0010872', 'T-wave inversion', 'MP:0031136', 'muscle hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230932, 'HP:0010872', 'T-wave inversion', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230933, 'HP:0010872', 'T-wave inversion', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230934, 'HP:0010872', 'T-wave inversion', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230935, 'HP:0010872', 'T-wave inversion', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230936, 'HP:0010872', 'T-wave inversion', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230937, 'HP:0010872', 'T-wave inversion', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230938, 'HP:0010872', 'T-wave inversion', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230939, 'HP:0010872', 'T-wave inversion', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230940, 'HP:0010872', 'T-wave inversion', 'MP:0011926', 'abnormal heart valve physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230941, 'HP:0010872', 'T-wave inversion', 'MP:0012045', 'increased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230942, 'HP:0010872', 'T-wave inversion', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230943, 'HP:0010872', 'T-wave inversion', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230944, 'HP:0010872', 'T-wave inversion', 'MP:0011920', 'abnormal S wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230945, 'HP:0010872', 'T-wave inversion', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230946, 'HP:0010872', 'T-wave inversion', 'MP:0010507', 'shortened RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230947, 'HP:0010872', 'T-wave inversion', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230948, 'HP:0010872', 'T-wave inversion', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230949, 'HP:0010872', 'T-wave inversion', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230950, 'HP:0010872', 'T-wave inversion', 'MP:0010560', 'intraventricular block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230951, 'HP:0010872', 'T-wave inversion', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230952, 'HP:0010872', 'T-wave inversion', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230953, 'HP:0010872', 'T-wave inversion', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230954, 'HP:0010872', 'T-wave inversion', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230955, 'HP:0010872', 'T-wave inversion', 'MP:0006111', 'abnormal coronary circulation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230956, 'HP:0010872', 'T-wave inversion', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230957, 'HP:0010872', 'T-wave inversion', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230958, 'HP:0010872', 'T-wave inversion', 'MP:0010512', 'absent PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230959, 'HP:0010872', 'T-wave inversion', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230960, 'HP:0010872', 'T-wave inversion', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230961, 'HP:0010872', 'T-wave inversion', 'MP:0010515', 'abnormal Q wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230962, 'HP:0010872', 'T-wave inversion', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230963, 'HP:0010872', 'T-wave inversion', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230964, 'HP:0010872', 'T-wave inversion', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230965, 'HP:0010872', 'T-wave inversion', 'MP:0031302', 'syncope', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230966, 'HP:0010872', 'T-wave inversion', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230967, 'HP:0010872', 'T-wave inversion', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230968, 'HP:0010872', 'T-wave inversion', 'MP:0011919', 'abnormal R wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230969, 'HP:0010872', 'T-wave inversion', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230970, 'HP:0010872', 'T-wave inversion', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230971, 'HP:0010872', 'T-wave inversion', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230972, 'HP:0010872', 'T-wave inversion', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230973, 'HP:0010872', 'T-wave inversion', 'MP:0031192', 'coronary artery spasm', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230974, 'HP:0010872', 'T-wave inversion', 'MP:0010394', 'decreased QRS amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230975, 'HP:0010872', 'T-wave inversion', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230976, 'HP:0010872', 'T-wave inversion', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230977, 'HP:0010872', 'T-wave inversion', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230978, 'HP:0010872', 'T-wave inversion', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230979, 'HP:0010872', 'T-wave inversion', 'MP:0003929', 'decreased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230980, 'HP:0010872', 'T-wave inversion', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230981, 'HP:0010872', 'T-wave inversion', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230982, 'HP:0010872', 'T-wave inversion', 'MP:0003037', 'increased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230983, 'HP:0010872', 'T-wave inversion', 'MP:0001598', 'abnormal blood viscosity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230984, 'HP:0010872', 'T-wave inversion', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230985, 'HP:0010872', 'T-wave inversion', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230986, 'HP:0010872', 'T-wave inversion', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230987, 'HP:0010872', 'T-wave inversion', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230988, 'HP:0010872', 'T-wave inversion', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230989, 'HP:0010872', 'T-wave inversion', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230990, 'HP:0010872', 'T-wave inversion', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230991, 'HP:0010872', 'T-wave inversion', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230992, 'HP:0010872', 'T-wave inversion', 'MP:0003896', 'prolonged PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230993, 'HP:0010872', 'T-wave inversion', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230994, 'HP:0010872', 'T-wave inversion', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230995, 'HP:0010872', 'T-wave inversion', 'MP:0004878', 'increased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230996, 'HP:0010872', 'T-wave inversion', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(230997, 'HP:0010872', 'T-wave inversion', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(230998, 'HP:0033408', 'Elevated circulating acetoacetic acid concentration', 'MP:0002575', 'increased circulating ketone body level', 0.4057971014492754, 13.491670050491338, 2.3398462770445807, 'UPHENO:0055032', 'increased ketone body biosynthetic process'),
(230999, 'HP:0033408', 'Elevated circulating acetoacetic acid concentration', 'MP:0030970', 'ketosis', 0.4230769230769231, 13.491670050491338, 2.389145088129005, 'UPHENO:0055032', 'increased ketone body biosynthetic process'),
(231000, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010420', 'muscular ventricular septal defect', 0.4375, 13.022184767190119, 2.3868820322013566, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231001, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0020135', 'abnormal heart ventricle wall thickness', 0.40476190476190477, 9.39444824277867, 1.950003785876895, 'UPHENO:0086866', 'abnormal cardiac ventricle morphology'),
(231002, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010402', 'ventricular septal defect', 0.4772727272727273, 13.022184767190119, 2.4930169752503075, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231003, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010577', 'abnormal heart right ventricle size', 0.4318181818181818, 10.533898285880637, 2.132774907313624, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(231004, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0008772', 'increased heart ventricle size', 0.4222222222222222, 10.533898285880637, 2.1089442721246523, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(231005, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0020136', 'abnormal interventricular septum thickness', 0.4772727272727273, 13.022184767190119, 2.4930169752503075, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231006, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010419', 'inlet ventricular septal defect', 0.4666666666666667, 13.022184767190119, 2.4651611626873517, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231007, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010725', 'thin interventricular septum', 0.42857142857142855, 13.022184767190119, 2.36240054368343, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231008, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010724', 'thick interventricular septum', 0.42, 13.022184767190119, 2.338657222044276, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231009, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010578', 'abnormal heart left ventricle size', 0.4318181818181818, 10.533898285880637, 2.132774907313624, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(231010, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010418', 'perimembraneous ventricular septal defect', 0.42857142857142855, 13.022184767190119, 2.36240054368343, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231011, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0010417', 'subarterial ventricular septal defect', 0.4666666666666667, 13.022184767190119, 2.4651611626873517, 'UPHENO:0019886', 'abnormal interventricular septum morphology'),
(231012, 'HP:0005144', 'Ventricular septal hypertrophy', 'MP:0005648', 'heart right ventricle degeneration', 0.4222222222222222, 10.533898285880637, 2.1089442721246523, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(231013, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40425531914893614, 9.692263881549227, 1.9794315418097665, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(231014, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0003670', 'dilated renal glomerular capsule', 0.41509433962264153, 9.692263881549227, 2.005792580343256, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(231015, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011293', 'dilated nephron', 0.40816326530612246, 8.69825431939161, 1.8842260706894922, 'UPHENO:0076756', 'abnormal nephron morphology'),
(231016, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011506', 'glomerular crescent', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231017, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.4423076923076923, 9.804092483287297, 2.082408586578051, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231018, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0020518', 'renal glomerular protein deposits', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231019, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011348', 'abnormal renal glomerulus basement membrane morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231020, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0021200', 'decreased susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231021, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231022, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0020519', 'renal glomerular immunoglobulin deposits', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231023, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011561', 'renal glomerulus lipidosis', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231024, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0002706', 'abnormal kidney size', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(231025, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0003985', 'renal fibrosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(231026, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231027, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0003197', 'nephrocalcinosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(231028, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0021201', 'increased susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231029, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4222222222222222, 9.692263881549227, 2.022940729342285, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(231030, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.43478260869565216, 9.804092483287297, 2.0646183438536734, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231031, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011859', 'decreased renal glomerulus basement membrane thickness', 0.40350877192982454, 9.804092483287297, 1.9889789636438293, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231032, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011483', 'renal glomerular synechia', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231033, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0005264', 'glomerulosclerosis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231034, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0000523', 'cortical renal glomerulopathies', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231035, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011567', 'increased renal glomerulus lobularity', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231036, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011377', 'renal glomerulus fibrosis', 0.45098039215686275, 9.804092483287297, 2.102725249017345, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231037, 'HP:0025006', 'Abnormal glomerular capillary morphology', 'MP:0011294', 'renal glomerulus hypertrophy', 0.42592592592592593, 9.804092483287297, 2.0434816291827906, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(231038, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014209', 'abnormal pancreatic duct epithelium physiology', 0.4864864864864865, 14.104646927382092, 2.6194885238982306, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231039, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0002164', 'abnormal gland physiology', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(231040, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014213', 'increased pancreatic duct epithelial chloride transmembrane transport', 0.45, 14.104646927382092, 2.519343390116151, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231041, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0002694', 'abnormal pancreas secretion', 0.46875, 11.852259765747807, 2.357063165295806, 'UPHENO:0002408', 'abnormality of pancreas physiology'),
(231042, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014096', 'abnormal pancreatic amylase secretion', 0.4090909090909091, 14.104646927382092, 2.402099671938914, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231043, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0013559', 'abnormal exocrine gland physiology', 0.45161290322580644, 11.126020578174659, 2.2415741019782334, 'UPHENO:0002400', 'abnormality of exocrine gland physiology'),
(231044, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0010377', 'abnormal gut flora balance', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(231045, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0003868', 'abnormal feces composition', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(231046, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0011911', 'abnormal pancreatic endocrine progenitor cell physiology', 0.40540540540540543, 11.852259765747807, 2.1920242186853605, 'UPHENO:0002408', 'abnormality of pancreas physiology'),
(231047, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0010994', 'aerophagia', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(231048, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0002693', 'abnormal pancreas physiology', 0.4838709677419355, 11.852259765747807, 2.394778570720307, 'UPHENO:0002408', 'abnormality of pancreas physiology'),
(231049, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0009147', 'abnormal pancreatic acinar cell physiology', 0.42857142857142855, 14.104646927382092, 2.458627398196757, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231050, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41935483870967744, 5.110459900932426, 1.4639317222766202, 'UPHENO:0002833', 'abnormal digestive system'),
(231051, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014030', 'abnormal mucous gland physiology', 0.42424242424242425, 11.126020578174659, 2.1725860034198683, 'UPHENO:0002400', 'abnormality of exocrine gland physiology'),
(231052, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014210', 'abnormal pancreatic duct epithelial transmembrane transport', 0.47368421052631576, 14.104646927382092, 2.5847917797279942, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231053, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014215', 'increased pancreatic duct epithelial sodium ion transmembrane transport', 0.45, 14.104646927382092, 2.519343390116151, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231054, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0010147', 'abnormal endocrine pancreas physiology', 0.4166666666666667, 11.852259765747807, 2.222260463820924, 'UPHENO:0002408', 'abnormality of pancreas physiology'),
(231055, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0011082', 'abnormal gastrointestinal motility', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(231056, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42424242424242425, 11.126020578174659, 2.1725860034198683, 'UPHENO:0002400', 'abnormality of exocrine gland physiology'),
(231057, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.45454545454545453, 11.852259765747807, 2.3210753547898095, 'UPHENO:0002408', 'abnormality of pancreas physiology'),
(231058, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42424242424242425, 11.126020578174659, 2.1725860034198683, 'UPHENO:0002400', 'abnormality of exocrine gland physiology'),
(231059, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0010148', 'abnormal exocrine pancreas physiology', 0.5, 14.104646927382092, 2.655621106952392, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231060, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0001663', 'abnormal digestive system physiology', 0.41935483870967744, 5.110459900932426, 1.4639317222766202, 'UPHENO:0002833', 'abnormal digestive system'),
(231061, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014214', 'abnormal pancreatic duct epithelial sodium ion transmembrane transport', 0.46153846153846156, 14.104646927382092, 2.55143823037265, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231062, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.46875, 11.852259765747807, 2.357063165295806, 'UPHENO:0002408', 'abnormality of pancreas physiology'),
(231063, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0008004', 'abnormal stomach pH', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(231064, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0003335', 'exocrine pancreatic insufficiency', 0.4864864864864865, 14.104646927382092, 2.6194885238982306, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231065, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014211', 'abnormal pancreatic duct epithelial chloride transmembrane transport', 0.46153846153846156, 14.104646927382092, 2.55143823037265, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231066, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42424242424242425, 11.126020578174659, 2.1725860034198683, 'UPHENO:0002400', 'abnormality of exocrine gland physiology'),
(231067, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0001664', 'abnormal digestion', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(231068, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014216', 'decreased pancreatic duct epithelial sodium ion transmembrane transport', 0.45, 14.104646927382092, 2.519343390116151, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231069, 'HP:0012092', 'Abnormality of exocrine pancreas physiology', 'MP:0014212', 'decreased pancreatic duct epithelial chloride transmembrane transport', 0.45, 14.104646927382092, 2.519343390116151, 'UPHENO:0002216', 'abnormality of exocrine pancreas physiology'),
(231070, 'HP:0500150', 'Hypoglutamatemia', 'MP:0005311', 'abnormal circulating amino acid level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(231071, 'HP:0500150', 'Hypoglutamatemia', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(231072, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231073, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231074, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231075, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231076, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231077, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231078, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231079, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231080, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231081, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231082, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231083, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231084, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231085, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231086, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231087, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231088, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231089, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231090, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231091, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231092, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231093, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231094, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231095, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231096, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231097, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231098, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231099, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231100, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231101, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231102, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231103, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231104, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231105, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231106, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231107, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231108, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231109, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231110, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231111, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231112, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231113, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231114, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231115, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231116, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231117, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231118, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231119, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231120, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231121, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231122, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231123, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231124, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231125, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231126, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231127, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231128, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231129, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231130, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231131, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231132, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231133, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231134, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231135, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231136, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231137, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231138, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231139, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231140, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231141, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231142, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231143, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231144, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231145, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231146, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231147, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231148, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231149, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231150, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231151, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231152, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231153, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231154, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231155, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231156, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231157, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231158, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231159, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231160, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231161, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231162, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231163, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231164, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231165, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231166, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231167, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231168, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231169, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231170, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231171, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231172, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231173, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231174, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231175, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231176, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231177, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231178, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231179, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231180, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231181, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231182, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231183, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231184, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231185, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231186, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231187, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231188, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231189, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231190, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231191, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231192, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231193, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231194, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231195, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231196, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231197, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231198, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231199, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231200, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231201, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231202, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231203, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231204, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231205, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231206, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231207, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231208, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231209, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231210, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231211, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231212, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231213, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231214, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231215, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231216, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231217, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231218, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231219, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231220, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231221, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231222, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231223, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231224, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231225, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231226, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231227, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231228, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231229, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231230, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231231, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231232, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231233, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231234, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231235, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231236, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231237, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231238, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231239, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231240, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231241, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231242, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231243, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231244, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231245, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231246, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231247, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231248, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231249, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231250, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231251, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231252, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231253, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231254, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231255, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231256, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231257, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231258, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231259, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231260, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231261, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231262, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231263, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231264, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231265, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231266, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231267, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231268, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231269, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231270, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231271, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231272, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231273, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231274, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231275, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231276, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231277, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231278, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231279, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231280, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231281, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231282, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231283, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231284, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231285, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231286, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231287, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231288, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231289, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231290, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231291, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231292, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231293, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231294, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231295, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231296, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231297, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231298, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231299, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231300, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231301, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231302, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231303, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231304, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231305, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231306, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231307, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231308, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231309, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231310, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231311, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231312, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231313, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231314, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231315, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231316, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231317, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231318, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231319, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231320, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231321, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231322, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231323, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231324, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231325, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231326, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231327, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231328, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231329, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231330, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231331, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231332, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231333, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231334, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231335, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231336, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231337, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231338, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231339, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231340, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231341, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231342, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231343, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231344, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231345, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231346, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231347, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231348, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231349, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231350, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231351, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231352, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231353, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231354, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231355, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231356, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231357, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231358, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231359, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231360, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231361, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231362, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231363, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231364, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231365, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231366, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231367, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231368, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231369, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231370, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231371, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231372, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231373, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231374, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231375, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231376, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231377, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231378, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231379, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231380, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231381, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231382, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231383, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231384, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231385, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231386, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231387, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231388, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231389, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231390, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231391, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231392, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231393, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231394, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231395, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231396, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231397, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231398, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231399, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231400, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231401, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231402, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231403, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231404, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231405, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231406, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231407, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231408, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231409, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231410, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231411, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231412, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231413, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231414, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231415, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231416, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231417, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231418, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231419, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231420, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231421, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231422, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231423, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231424, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231425, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231426, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231427, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231428, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231429, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231430, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231431, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231432, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231433, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231434, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231435, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231436, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231437, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231438, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231439, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231440, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231441, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231442, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231443, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231444, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231445, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231446, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231447, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231448, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231449, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231450, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231451, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231452, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231453, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231454, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231455, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231456, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231457, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231458, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231459, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231460, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231461, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231462, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231463, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231464, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231465, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231466, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231467, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231468, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231469, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231470, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231471, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231472, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231473, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231474, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231475, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231476, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231477, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231478, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231479, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231480, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231481, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231482, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231483, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231484, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231485, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231486, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231487, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231488, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231489, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231490, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231491, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231492, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231493, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231494, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231495, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231496, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231497, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231498, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231499, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231500, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231501, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231502, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231503, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231504, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231505, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231506, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231507, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231508, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231509, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231510, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231511, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231512, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231513, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231514, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231515, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231516, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231517, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231518, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231519, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231520, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231521, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231522, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231523, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231524, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231525, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231526, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231527, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231528, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231529, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231530, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231531, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231532, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231533, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231534, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231535, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231536, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231537, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231538, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231539, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231540, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231541, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231542, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231543, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231544, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231545, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231546, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231547, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231548, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231549, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231550, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231551, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231552, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231553, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231554, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231555, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231556, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231557, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231558, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231559, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231560, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231561, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231562, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231563, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231564, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231565, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231566, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231567, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231568, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231569, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231570, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231571, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231572, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231573, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231574, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231575, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231576, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231577, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231578, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231579, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231580, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231581, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231582, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231583, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231584, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231585, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231586, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231587, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231588, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231589, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231590, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231591, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231592, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231593, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231594, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231595, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231596, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231597, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231598, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231599, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231600, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231601, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231602, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231603, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231604, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231605, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231606, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231607, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231608, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231609, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231610, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231611, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231612, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231613, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231614, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231615, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231616, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231617, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231618, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231619, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231620, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231621, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231622, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231623, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231624, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231625, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231626, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231627, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231628, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231629, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231630, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231631, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231632, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231633, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231634, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231635, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231636, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231637, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231638, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231639, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231640, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231641, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231642, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231643, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231644, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231645, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231646, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231647, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231648, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231649, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231650, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231651, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231652, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231653, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231654, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231655, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231656, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231657, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231658, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231659, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231660, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231661, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231662, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231663, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231664, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231665, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231666, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231667, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231668, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231669, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231670, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231671, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231672, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231673, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231674, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231675, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231676, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231677, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231678, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231679, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231680, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231681, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231682, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231683, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231684, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231685, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231686, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231687, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231688, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231689, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231690, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231691, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231692, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231693, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231694, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231695, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231696, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231697, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231698, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231699, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231700, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231701, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231702, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231703, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231704, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231705, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231706, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231707, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231708, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231709, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231710, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231711, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231712, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231713, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231714, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231715, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231716, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231717, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231718, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231719, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231720, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231721, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231722, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231723, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231724, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231725, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231726, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231727, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231728, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231729, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231730, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231731, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231732, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231733, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231734, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231735, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231736, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231737, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231738, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231739, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231740, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231741, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231742, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231743, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231744, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231745, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231746, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231747, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231748, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231749, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231750, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231751, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231752, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231753, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231754, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231755, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231756, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231757, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231758, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231759, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231760, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231761, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231762, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231763, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231764, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231765, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231766, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231767, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231768, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231769, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231770, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231771, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231772, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231773, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231774, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231775, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231776, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231777, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231778, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231779, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231780, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231781, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231782, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231783, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231784, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231785, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231786, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231787, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231788, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231789, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231790, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231791, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231792, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231793, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231794, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231795, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231796, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231797, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231798, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231799, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231800, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231801, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231802, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231803, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231804, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231805, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231806, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231807, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231808, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231809, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231810, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231811, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231812, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231813, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231814, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231815, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231816, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231817, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231818, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231819, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231820, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231821, 'HP:0034092', 'Anti-cyclic citrullinated peptide antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231822, 'HP:0002730', 'Chronic noninfectious lymphadenopathy', 'MP:0004106', 'lymphatic vessel hyperplasia', 0.42857142857142855, 10.052558416233639, 2.0756298613295647, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(231823, 'HP:0002730', 'Chronic noninfectious lymphadenopathy', 'MP:0000702', 'enlarged lymph nodes', 0.4375, 13.285219173023913, 2.410867766634653, 'UPHENO:0001209', 'increased size of the lymph node'),
(231824, 'HP:0002730', 'Chronic noninfectious lymphadenopathy', 'MP:0031094', 'organomegaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(231825, 'HP:0002730', 'Chronic noninfectious lymphadenopathy', 'MP:0008102', 'lymph node hyperplasia', 0.46938775510204084, 14.384754846574829, 2.598466429478542, 'UPHENO:0083593', 'lymph node hyperplasia'),
(231826, 'HP:0002730', 'Chronic noninfectious lymphadenopathy', 'MP:0010200', 'enlarged lymphatic vessel', 0.425531914893617, 9.906707549770184, 2.0531975633009014, 'UPHENO:0075774', 'abnormal lymphatic part of lymphoid system'),
(231827, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0001140', 'abnormal vagina epithelium morphology', 0.4186046511627907, 12.410750055107771, 2.279297632492732, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231828, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009070', 'small oviduct', 0.45652173913043476, 12.410750055107771, 2.380289309951826, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231829, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0031390', 'myometrium hyperplasia', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231830, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003534', 'blind vagina', 0.4146341463414634, 9.668547812575419, 2.002226278078687, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231831, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0004906', 'enlarged uterus', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231832, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0008978', 'abnormal vagina weight', 0.43478260869565216, 9.668547812575419, 2.050296671277155, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231833, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003568', 'uterus atresia', 0.4444444444444444, 9.668547812575419, 2.072952570886423, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231834, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003576', 'oviduct hypoplasia', 0.40384615384615385, 12.410750055107771, 2.2387571722054216, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231835, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0011873', 'enlarged uterine horn', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231836, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003574', 'abnormal oviduct morphology', 0.46153846153846156, 12.410750055107771, 2.3933320887358733, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231837, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009084', 'blind uterus', 0.40476190476190477, 9.668547812575419, 1.978246655222643, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231838, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0013399', 'endometrium fibrosis', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231839, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009092', 'endometrium hyperplasia', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231840, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0013398', 'uterus fibrosis', 0.45454545454545453, 9.668547812575419, 2.0963765072766756, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231841, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009466', 'abnormal uterine tube infundibulum morphology', 0.43902439024390244, 12.410750055107771, 2.3342283468875036, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231842, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009209', 'abnormal internal female genitalia morphology', 0.4473684210526316, 9.668547812575419, 2.079760315224747, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231843, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009069', 'dilated oviduct', 0.42857142857142855, 12.410750055107771, 2.3062725079141178, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231844, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0004903', 'abnormal uterus weight', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231845, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009359', 'endometrium atrophy', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231846, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009077', 'abnormal cranial vagina morphology', 0.4186046511627907, 12.410750055107771, 2.279297632492732, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231847, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0011644', 'abnormal oviduct epithelium motile cilium morphology', 0.4117647058823529, 12.410750055107771, 2.2605992228214284, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231848, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003575', 'absent oviduct', 0.40425531914893614, 12.410750055107771, 2.2398910072602347, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231849, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003571', 'uterus rupture', 0.45454545454545453, 9.668547812575419, 2.0963765072766756, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231850, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009065', 'abnormal oviduct weight', 0.4666666666666667, 12.410750055107771, 2.406591647756281, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231851, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0004902', 'abnormal uterus size', 0.45454545454545453, 9.668547812575419, 2.0963765072766756, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231852, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003533', 'bifid vagina', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231853, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0008977', 'abnormal vagina size', 0.46511627906976744, 9.668547812575419, 2.120612879002959, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231854, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0001141', 'thickened vaginal epithelium', 0.4117647058823529, 12.410750055107771, 2.2605992228214284, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231855, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009063', 'abnormal oviduct size', 0.5, 12.410750055107771, 2.4910590172763643, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231856, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003531', 'abnormal vagina development', 0.40476190476190477, 9.668547812575419, 1.978246655222643, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231857, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009068', 'enlarged oviduct', 0.45652173913043476, 12.410750055107771, 2.380289309951826, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231858, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0001139', 'abnormal vagina morphology', 0.425, 9.668547812575419, 2.0270996078990673, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231859, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009064', 'oviduct atrophy', 0.42857142857142855, 12.410750055107771, 2.3062725079141178, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231860, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0001142', 'abnormal vagina orifice morphology', 0.40476190476190477, 9.668547812575419, 1.978246655222643, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231861, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0011645', 'absent oviduct epithelium motile cilium', 0.40384615384615385, 12.410750055107771, 2.2387571722054216, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231862, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0002637', 'small uterus', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231863, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009708', 'vaginal septum', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231864, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009071', 'short oviduct', 0.4117647058823529, 12.410750055107771, 2.2605992228214284, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231865, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009225', 'abnormal uterine cervix size', 0.43478260869565216, 9.668547812575419, 2.050296671277155, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231866, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0001144', 'vagina atresia', 0.43478260869565216, 9.668547812575419, 2.050296671277155, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231867, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003618', 'uterine cervical atresia', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231868, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0008981', 'enlarged vagina', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231869, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009709', 'hydrometra', 0.40476190476190477, 9.668547812575419, 1.978246655222643, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231870, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009067', 'increased oviduct weight', 0.40384615384615385, 12.410750055107771, 2.2387571722054216, 'UPHENO:0076717', 'abnormal fallopian tube morphology'),
(231871, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0001120', 'abnormal uterus morphology', 0.4146341463414634, 9.668547812575419, 2.002226278078687, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231872, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003537', 'hydrometrocolpos', 0.4146341463414634, 9.668547812575419, 2.002226278078687, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231873, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0003536', 'vagina dryness', 0.4186046511627907, 9.668547812575419, 2.011790019940922, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231874, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0008983', 'small vagina', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231875, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009208', 'abnormal female genitalia morphology', 0.40540540540540543, 9.027202841956743, 1.9130281827041393, 'UPHENO:0087806', 'abnormal female reproductive organ morphology'),
(231876, 'HP:0011027', 'Abnormal fallopian tube morphology', 'MP:0009221', 'uterus adenomyosis', 0.40476190476190477, 9.668547812575419, 1.978246655222643, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(231877, 'HP:0002383', 'Infectious encephalitis', 'MP:0005001', 'abnormal clonal deletion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231878, 'HP:0002383', 'Infectious encephalitis', 'MP:0001800', 'abnormal humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231879, 'HP:0002383', 'Infectious encephalitis', 'MP:0002419', 'abnormal innate immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231880, 'HP:0002383', 'Infectious encephalitis', 'MP:0005005', 'abnormal self tolerance', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231881, 'HP:0002383', 'Infectious encephalitis', 'MP:0000920', 'abnormal myelination', 0.4166666666666667, 5.059610039003922, 1.4519541485821676, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231882, 'HP:0002383', 'Infectious encephalitis', 'MP:0001846', 'increased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231883, 'HP:0002383', 'Infectious encephalitis', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231884, 'HP:0002383', 'Infectious encephalitis', 'MP:0020000', 'abnormal response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231885, 'HP:0002383', 'Infectious encephalitis', 'MP:0004752', 'decreased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231886, 'HP:0002383', 'Infectious encephalitis', 'MP:0010050', 'hypermyelination', 0.40540540540540543, 5.059610039003922, 1.4321987498443238, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231887, 'HP:0002383', 'Infectious encephalitis', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231888, 'HP:0002383', 'Infectious encephalitis', 'MP:0001876', 'decreased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231889, 'HP:0002383', 'Infectious encephalitis', 'MP:0005025', 'abnormal response to infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231890, 'HP:0002383', 'Infectious encephalitis', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231891, 'HP:0002383', 'Infectious encephalitis', 'MP:0003009', 'abnormal cytokine secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231892, 'HP:0002383', 'Infectious encephalitis', 'MP:0001835', 'abnormal antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231893, 'HP:0002383', 'Infectious encephalitis', 'MP:0005671', 'abnormal response to transplant', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231894, 'HP:0002383', 'Infectious encephalitis', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231895, 'HP:0002383', 'Infectious encephalitis', 'MP:0013438', 'dysmyelination', 0.40540540540540543, 5.059610039003922, 1.4321987498443238, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231896, 'HP:0002383', 'Infectious encephalitis', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231897, 'HP:0002383', 'Infectious encephalitis', 'MP:0002498', 'abnormal acute inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231898, 'HP:0002383', 'Infectious encephalitis', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231899, 'HP:0002383', 'Infectious encephalitis', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231900, 'HP:0002383', 'Infectious encephalitis', 'MP:0002420', 'abnormal adaptive immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231901, 'HP:0002383', 'Infectious encephalitis', 'MP:0020154', 'impaired humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231902, 'HP:0002383', 'Infectious encephalitis', 'MP:0001790', 'abnormal immune system physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231903, 'HP:0002383', 'Infectious encephalitis', 'MP:0020155', 'enhanced humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231904, 'HP:0002383', 'Infectious encephalitis', 'MP:0003762', 'abnormal immune organ physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231905, 'HP:0002383', 'Infectious encephalitis', 'MP:0020001', 'decreased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231906, 'HP:0002383', 'Infectious encephalitis', 'MP:0020002', 'increased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231907, 'HP:0002383', 'Infectious encephalitis', 'MP:0004751', 'increased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231908, 'HP:0002383', 'Infectious encephalitis', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231909, 'HP:0002383', 'Infectious encephalitis', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231910, 'HP:0002383', 'Infectious encephalitis', 'MP:0001845', 'abnormal inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231911, 'HP:0002383', 'Infectious encephalitis', 'MP:0000921', 'demyelination', 0.40540540540540543, 5.059610039003922, 1.4321987498443238, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231912, 'HP:0002383', 'Infectious encephalitis', 'MP:0005000', 'abnormal immune tolerance', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231913, 'HP:0002383', 'Infectious encephalitis', 'MP:0002499', 'chronic inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(231914, 'HP:0010641', 'Abnormality of the midnasal cavity', 'MP:0031101', 'nasal obstruction', 0.423728813559322, 12.799792345853673, 2.328871148113237, 'UPHENO:0075984', 'abnormal nasal cavity'),
(231915, 'HP:5200043', 'Abnormal speech volume', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231916, 'HP:5200043', 'Abnormal speech volume', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231917, 'HP:5200043', 'Abnormal speech volume', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231918, 'HP:5200043', 'Abnormal speech volume', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231919, 'HP:5200043', 'Abnormal speech volume', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231920, 'HP:5200043', 'Abnormal speech volume', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231921, 'HP:5200043', 'Abnormal speech volume', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231922, 'HP:5200043', 'Abnormal speech volume', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231923, 'HP:5200043', 'Abnormal speech volume', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231924, 'HP:5200043', 'Abnormal speech volume', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231925, 'HP:5200043', 'Abnormal speech volume', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231926, 'HP:5200043', 'Abnormal speech volume', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231927, 'HP:5200043', 'Abnormal speech volume', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231928, 'HP:5200043', 'Abnormal speech volume', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231929, 'HP:5200043', 'Abnormal speech volume', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231930, 'HP:5200043', 'Abnormal speech volume', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231931, 'HP:5200043', 'Abnormal speech volume', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231932, 'HP:5200043', 'Abnormal speech volume', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231933, 'HP:5200043', 'Abnormal speech volume', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231934, 'HP:5200043', 'Abnormal speech volume', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231935, 'HP:5200043', 'Abnormal speech volume', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231936, 'HP:5200043', 'Abnormal speech volume', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231937, 'HP:5200043', 'Abnormal speech volume', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231938, 'HP:5200043', 'Abnormal speech volume', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231939, 'HP:5200043', 'Abnormal speech volume', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231940, 'HP:5200043', 'Abnormal speech volume', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231941, 'HP:5200043', 'Abnormal speech volume', 'MP:0031110', 'meningitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231942, 'HP:5200043', 'Abnormal speech volume', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231943, 'HP:5200043', 'Abnormal speech volume', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231944, 'HP:5200043', 'Abnormal speech volume', 'MP:0003088', 'abnormal prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231945, 'HP:5200043', 'Abnormal speech volume', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231946, 'HP:5200043', 'Abnormal speech volume', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231947, 'HP:5200043', 'Abnormal speech volume', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231948, 'HP:5200043', 'Abnormal speech volume', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231949, 'HP:5200043', 'Abnormal speech volume', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231950, 'HP:5200043', 'Abnormal speech volume', 'MP:0012011', 'febrile seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231951, 'HP:5200043', 'Abnormal speech volume', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231952, 'HP:5200043', 'Abnormal speech volume', 'MP:0003996', 'clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231953, 'HP:5200043', 'Abnormal speech volume', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231954, 'HP:5200043', 'Abnormal speech volume', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231955, 'HP:5200043', 'Abnormal speech volume', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231956, 'HP:5200043', 'Abnormal speech volume', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231957, 'HP:5200043', 'Abnormal speech volume', 'MP:0006058', 'decreased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231958, 'HP:5200043', 'Abnormal speech volume', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231959, 'HP:5200043', 'Abnormal speech volume', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231960, 'HP:5200043', 'Abnormal speech volume', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231961, 'HP:5200043', 'Abnormal speech volume', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231962, 'HP:5200043', 'Abnormal speech volume', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231963, 'HP:5200043', 'Abnormal speech volume', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231964, 'HP:5200043', 'Abnormal speech volume', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231965, 'HP:5200043', 'Abnormal speech volume', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231966, 'HP:5200043', 'Abnormal speech volume', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231967, 'HP:5200043', 'Abnormal speech volume', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231968, 'HP:5200043', 'Abnormal speech volume', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231969, 'HP:5200043', 'Abnormal speech volume', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231970, 'HP:5200043', 'Abnormal speech volume', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231971, 'HP:5200043', 'Abnormal speech volume', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231972, 'HP:5200043', 'Abnormal speech volume', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231973, 'HP:5200043', 'Abnormal speech volume', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231974, 'HP:5200043', 'Abnormal speech volume', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231975, 'HP:5200043', 'Abnormal speech volume', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231976, 'HP:5200043', 'Abnormal speech volume', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231977, 'HP:5200043', 'Abnormal speech volume', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231978, 'HP:5200043', 'Abnormal speech volume', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231979, 'HP:5200043', 'Abnormal speech volume', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231980, 'HP:5200043', 'Abnormal speech volume', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231981, 'HP:5200043', 'Abnormal speech volume', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231982, 'HP:5200043', 'Abnormal speech volume', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231983, 'HP:5200043', 'Abnormal speech volume', 'MP:0004859', 'abnormal synaptic plasticity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231984, 'HP:5200043', 'Abnormal speech volume', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231985, 'HP:5200043', 'Abnormal speech volume', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231986, 'HP:5200043', 'Abnormal speech volume', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231987, 'HP:5200043', 'Abnormal speech volume', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231988, 'HP:5200043', 'Abnormal speech volume', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231989, 'HP:5200043', 'Abnormal speech volume', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231990, 'HP:5200043', 'Abnormal speech volume', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231991, 'HP:5200043', 'Abnormal speech volume', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231992, 'HP:5200043', 'Abnormal speech volume', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231993, 'HP:5200043', 'Abnormal speech volume', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231994, 'HP:5200043', 'Abnormal speech volume', 'MP:0012502', 'decreased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(231995, 'HP:5200043', 'Abnormal speech volume', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231996, 'HP:5200043', 'Abnormal speech volume', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231997, 'HP:5200043', 'Abnormal speech volume', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231998, 'HP:5200043', 'Abnormal speech volume', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(231999, 'HP:5200043', 'Abnormal speech volume', 'MP:0003466', 'decreased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232000, 'HP:5200043', 'Abnormal speech volume', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232001, 'HP:5200043', 'Abnormal speech volume', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232002, 'HP:5200043', 'Abnormal speech volume', 'MP:0002193', 'minimal clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232003, 'HP:5200043', 'Abnormal speech volume', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232004, 'HP:5200043', 'Abnormal speech volume', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232005, 'HP:5200043', 'Abnormal speech volume', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232006, 'HP:5200043', 'Abnormal speech volume', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232007, 'HP:5200043', 'Abnormal speech volume', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232008, 'HP:5200043', 'Abnormal speech volume', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232009, 'HP:5200043', 'Abnormal speech volume', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232010, 'HP:5200043', 'Abnormal speech volume', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232011, 'HP:5200043', 'Abnormal speech volume', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232012, 'HP:5200043', 'Abnormal speech volume', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232013, 'HP:5200043', 'Abnormal speech volume', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232014, 'HP:5200043', 'Abnormal speech volume', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232015, 'HP:5200043', 'Abnormal speech volume', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232016, 'HP:5200043', 'Abnormal speech volume', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232017, 'HP:5200043', 'Abnormal speech volume', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232018, 'HP:5200043', 'Abnormal speech volume', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232019, 'HP:5200043', 'Abnormal speech volume', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232020, 'HP:5200043', 'Abnormal speech volume', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232021, 'HP:5200043', 'Abnormal speech volume', 'MP:0003463', 'abnormal single cell response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232022, 'HP:5200043', 'Abnormal speech volume', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232023, 'HP:5200043', 'Abnormal speech volume', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232024, 'HP:5200043', 'Abnormal speech volume', 'MP:0003488', 'decreased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232025, 'HP:5200043', 'Abnormal speech volume', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232026, 'HP:5200043', 'Abnormal speech volume', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232027, 'HP:5200043', 'Abnormal speech volume', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232028, 'HP:5200043', 'Abnormal speech volume', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232029, 'HP:5200043', 'Abnormal speech volume', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232030, 'HP:5200043', 'Abnormal speech volume', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232031, 'HP:5200043', 'Abnormal speech volume', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232032, 'HP:5200043', 'Abnormal speech volume', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232033, 'HP:5200043', 'Abnormal speech volume', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232034, 'HP:5200043', 'Abnormal speech volume', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232035, 'HP:5200043', 'Abnormal speech volume', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232036, 'HP:5200043', 'Abnormal speech volume', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232037, 'HP:5200043', 'Abnormal speech volume', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232038, 'HP:5200043', 'Abnormal speech volume', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232039, 'HP:5200043', 'Abnormal speech volume', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232040, 'HP:5200043', 'Abnormal speech volume', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232041, 'HP:5200043', 'Abnormal speech volume', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232042, 'HP:5200043', 'Abnormal speech volume', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232043, 'HP:5200043', 'Abnormal speech volume', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232044, 'HP:5200043', 'Abnormal speech volume', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232045, 'HP:5200043', 'Abnormal speech volume', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232046, 'HP:5200043', 'Abnormal speech volume', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232047, 'HP:5200043', 'Abnormal speech volume', 'MP:0002923', 'increased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232048, 'HP:5200043', 'Abnormal speech volume', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232049, 'HP:5200043', 'Abnormal speech volume', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232050, 'HP:5200043', 'Abnormal speech volume', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232051, 'HP:5200043', 'Abnormal speech volume', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232052, 'HP:5200043', 'Abnormal speech volume', 'MP:0005403', 'abnormal nerve conduction', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232053, 'HP:5200043', 'Abnormal speech volume', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232054, 'HP:5200043', 'Abnormal speech volume', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232055, 'HP:5200043', 'Abnormal speech volume', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232056, 'HP:5200043', 'Abnormal speech volume', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232057, 'HP:5200043', 'Abnormal speech volume', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232058, 'HP:5200043', 'Abnormal speech volume', 'MP:0003470', 'abnormal summary potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232059, 'HP:5200043', 'Abnormal speech volume', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232060, 'HP:5200043', 'Abnormal speech volume', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232061, 'HP:5200043', 'Abnormal speech volume', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232062, 'HP:5200043', 'Abnormal speech volume', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232063, 'HP:5200043', 'Abnormal speech volume', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232064, 'HP:5200043', 'Abnormal speech volume', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232065, 'HP:5200043', 'Abnormal speech volume', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232066, 'HP:5200043', 'Abnormal speech volume', 'MP:0001473', 'reduced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232067, 'HP:5200043', 'Abnormal speech volume', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232068, 'HP:5200043', 'Abnormal speech volume', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232069, 'HP:5200043', 'Abnormal speech volume', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232070, 'HP:5200043', 'Abnormal speech volume', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232071, 'HP:5200043', 'Abnormal speech volume', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232072, 'HP:5200043', 'Abnormal speech volume', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232073, 'HP:5200043', 'Abnormal speech volume', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232074, 'HP:5200043', 'Abnormal speech volume', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232075, 'HP:5200043', 'Abnormal speech volume', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232076, 'HP:5200043', 'Abnormal speech volume', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232077, 'HP:5200043', 'Abnormal speech volume', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232078, 'HP:5200043', 'Abnormal speech volume', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232079, 'HP:5200043', 'Abnormal speech volume', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232080, 'HP:5200043', 'Abnormal speech volume', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232081, 'HP:5200043', 'Abnormal speech volume', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232082, 'HP:5200043', 'Abnormal speech volume', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232083, 'HP:5200043', 'Abnormal speech volume', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232084, 'HP:5200043', 'Abnormal speech volume', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232085, 'HP:5200043', 'Abnormal speech volume', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232086, 'HP:5200043', 'Abnormal speech volume', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232087, 'HP:5200043', 'Abnormal speech volume', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232088, 'HP:5200043', 'Abnormal speech volume', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232089, 'HP:5200043', 'Abnormal speech volume', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232090, 'HP:5200043', 'Abnormal speech volume', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232091, 'HP:5200043', 'Abnormal speech volume', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232092, 'HP:5200043', 'Abnormal speech volume', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232093, 'HP:5200043', 'Abnormal speech volume', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232094, 'HP:5200043', 'Abnormal speech volume', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232095, 'HP:5200043', 'Abnormal speech volume', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232096, 'HP:5200043', 'Abnormal speech volume', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232097, 'HP:5200043', 'Abnormal speech volume', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232098, 'HP:5200043', 'Abnormal speech volume', 'MP:0002916', 'increased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232099, 'HP:5200043', 'Abnormal speech volume', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232100, 'HP:5200043', 'Abnormal speech volume', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232101, 'HP:5200043', 'Abnormal speech volume', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232102, 'HP:5200043', 'Abnormal speech volume', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232103, 'HP:5200043', 'Abnormal speech volume', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232104, 'HP:5200043', 'Abnormal speech volume', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232105, 'HP:5200043', 'Abnormal speech volume', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232106, 'HP:5200043', 'Abnormal speech volume', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232107, 'HP:5200043', 'Abnormal speech volume', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232108, 'HP:5200043', 'Abnormal speech volume', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232109, 'HP:5200043', 'Abnormal speech volume', 'MP:0003474', 'abnormal summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232110, 'HP:5200043', 'Abnormal speech volume', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232111, 'HP:5200043', 'Abnormal speech volume', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232112, 'HP:5200043', 'Abnormal speech volume', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232113, 'HP:5200043', 'Abnormal speech volume', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232114, 'HP:5200043', 'Abnormal speech volume', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232115, 'HP:5200043', 'Abnormal speech volume', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232116, 'HP:5200043', 'Abnormal speech volume', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232117, 'HP:5200043', 'Abnormal speech volume', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232118, 'HP:5200043', 'Abnormal speech volume', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232119, 'HP:5200043', 'Abnormal speech volume', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232120, 'HP:5200043', 'Abnormal speech volume', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232121, 'HP:5200043', 'Abnormal speech volume', 'MP:0003880', 'abnormal central pattern generator function', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232122, 'HP:5200043', 'Abnormal speech volume', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232123, 'HP:5200043', 'Abnormal speech volume', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232124, 'HP:5200043', 'Abnormal speech volume', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232125, 'HP:5200043', 'Abnormal speech volume', 'MP:0003219', 'increased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232126, 'HP:5200043', 'Abnormal speech volume', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232127, 'HP:5200043', 'Abnormal speech volume', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232128, 'HP:5200043', 'Abnormal speech volume', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232129, 'HP:5200043', 'Abnormal speech volume', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232130, 'HP:5200043', 'Abnormal speech volume', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232131, 'HP:5200043', 'Abnormal speech volume', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232132, 'HP:5200043', 'Abnormal speech volume', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232133, 'HP:5200043', 'Abnormal speech volume', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232134, 'HP:5200043', 'Abnormal speech volume', 'MP:0008921', 'increased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232135, 'HP:5200043', 'Abnormal speech volume', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232136, 'HP:5200043', 'Abnormal speech volume', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232137, 'HP:5200043', 'Abnormal speech volume', 'MP:0002207', 'abnormal long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232138, 'HP:5200043', 'Abnormal speech volume', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232139, 'HP:5200043', 'Abnormal speech volume', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232140, 'HP:5200043', 'Abnormal speech volume', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232141, 'HP:5200043', 'Abnormal speech volume', 'MP:0004994', 'abnormal brain wave pattern', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232142, 'HP:5200043', 'Abnormal speech volume', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232143, 'HP:5200043', 'Abnormal speech volume', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232144, 'HP:5200043', 'Abnormal speech volume', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232145, 'HP:5200043', 'Abnormal speech volume', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232146, 'HP:5200043', 'Abnormal speech volume', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232147, 'HP:5200043', 'Abnormal speech volume', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232148, 'HP:5200043', 'Abnormal speech volume', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232149, 'HP:5200043', 'Abnormal speech volume', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232150, 'HP:5200043', 'Abnormal speech volume', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232151, 'HP:5200043', 'Abnormal speech volume', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232152, 'HP:5200043', 'Abnormal speech volume', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232153, 'HP:5200043', 'Abnormal speech volume', 'MP:0006053', 'hypothalamus hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232154, 'HP:5200043', 'Abnormal speech volume', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232155, 'HP:5200043', 'Abnormal speech volume', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232156, 'HP:5200043', 'Abnormal speech volume', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232157, 'HP:5200043', 'Abnormal speech volume', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232158, 'HP:5200043', 'Abnormal speech volume', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232159, 'HP:5200043', 'Abnormal speech volume', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232160, 'HP:5200043', 'Abnormal speech volume', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232161, 'HP:5200043', 'Abnormal speech volume', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232162, 'HP:5200043', 'Abnormal speech volume', 'MP:0012504', 'increased forebrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232163, 'HP:5200043', 'Abnormal speech volume', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232164, 'HP:5200043', 'Abnormal speech volume', 'MP:0006080', 'brain ischemia', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232165, 'HP:5200043', 'Abnormal speech volume', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232166, 'HP:5200043', 'Abnormal speech volume', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232167, 'HP:5200043', 'Abnormal speech volume', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232168, 'HP:5200043', 'Abnormal speech volume', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232169, 'HP:5200043', 'Abnormal speech volume', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232170, 'HP:5200043', 'Abnormal speech volume', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232171, 'HP:5200043', 'Abnormal speech volume', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232172, 'HP:5200043', 'Abnormal speech volume', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232173, 'HP:5200043', 'Abnormal speech volume', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232174, 'HP:5200043', 'Abnormal speech volume', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232175, 'HP:5200043', 'Abnormal speech volume', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232176, 'HP:5200043', 'Abnormal speech volume', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232177, 'HP:5200043', 'Abnormal speech volume', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232178, 'HP:5200043', 'Abnormal speech volume', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232179, 'HP:5200043', 'Abnormal speech volume', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232180, 'HP:5200043', 'Abnormal speech volume', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232181, 'HP:5200043', 'Abnormal speech volume', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232182, 'HP:5200043', 'Abnormal speech volume', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232183, 'HP:5200043', 'Abnormal speech volume', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232184, 'HP:5200043', 'Abnormal speech volume', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232185, 'HP:5200043', 'Abnormal speech volume', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232186, 'HP:5200043', 'Abnormal speech volume', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232187, 'HP:5200043', 'Abnormal speech volume', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232188, 'HP:5200043', 'Abnormal speech volume', 'MP:0002920', 'decreased paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232189, 'HP:5200043', 'Abnormal speech volume', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232190, 'HP:5200043', 'Abnormal speech volume', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232191, 'HP:5200043', 'Abnormal speech volume', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232192, 'HP:5200043', 'Abnormal speech volume', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232193, 'HP:5200043', 'Abnormal speech volume', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232194, 'HP:5200043', 'Abnormal speech volume', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232195, 'HP:5200043', 'Abnormal speech volume', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232196, 'HP:5200043', 'Abnormal speech volume', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232197, 'HP:5200043', 'Abnormal speech volume', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232198, 'HP:5200043', 'Abnormal speech volume', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232199, 'HP:5200043', 'Abnormal speech volume', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232200, 'HP:5200043', 'Abnormal speech volume', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232201, 'HP:5200043', 'Abnormal speech volume', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232202, 'HP:5200043', 'Abnormal speech volume', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232203, 'HP:5200043', 'Abnormal speech volume', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232204, 'HP:5200043', 'Abnormal speech volume', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232205, 'HP:5200043', 'Abnormal speech volume', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232206, 'HP:5200043', 'Abnormal speech volume', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232207, 'HP:5200043', 'Abnormal speech volume', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232208, 'HP:5200043', 'Abnormal speech volume', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232209, 'HP:5200043', 'Abnormal speech volume', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232210, 'HP:5200043', 'Abnormal speech volume', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232211, 'HP:5200043', 'Abnormal speech volume', 'MP:0003484', 'abnormal channel response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232212, 'HP:5200043', 'Abnormal speech volume', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232213, 'HP:5200043', 'Abnormal speech volume', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232214, 'HP:5200043', 'Abnormal speech volume', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232215, 'HP:5200043', 'Abnormal speech volume', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232216, 'HP:5200043', 'Abnormal speech volume', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232217, 'HP:5200043', 'Abnormal speech volume', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232218, 'HP:5200043', 'Abnormal speech volume', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232219, 'HP:5200043', 'Abnormal speech volume', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232220, 'HP:5200043', 'Abnormal speech volume', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232221, 'HP:5200043', 'Abnormal speech volume', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232222, 'HP:5200043', 'Abnormal speech volume', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232223, 'HP:5200043', 'Abnormal speech volume', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232224, 'HP:5200043', 'Abnormal speech volume', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232225, 'HP:5200043', 'Abnormal speech volume', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232226, 'HP:5200043', 'Abnormal speech volume', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232227, 'HP:5200043', 'Abnormal speech volume', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232228, 'HP:5200043', 'Abnormal speech volume', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232229, 'HP:5200043', 'Abnormal speech volume', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232230, 'HP:5200043', 'Abnormal speech volume', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232231, 'HP:5200043', 'Abnormal speech volume', 'MP:0013806', 'encephalopathy', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232232, 'HP:5200043', 'Abnormal speech volume', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232233, 'HP:5200043', 'Abnormal speech volume', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232234, 'HP:5200043', 'Abnormal speech volume', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232235, 'HP:5200043', 'Abnormal speech volume', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232236, 'HP:5200043', 'Abnormal speech volume', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232237, 'HP:5200043', 'Abnormal speech volume', 'MP:0001898', 'abnormal long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232238, 'HP:5200043', 'Abnormal speech volume', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232239, 'HP:5200043', 'Abnormal speech volume', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232240, 'HP:5200043', 'Abnormal speech volume', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232241, 'HP:5200043', 'Abnormal speech volume', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232242, 'HP:5200043', 'Abnormal speech volume', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232243, 'HP:5200043', 'Abnormal speech volume', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232244, 'HP:5200043', 'Abnormal speech volume', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232245, 'HP:5200043', 'Abnormal speech volume', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232246, 'HP:5200043', 'Abnormal speech volume', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232247, 'HP:5200043', 'Abnormal speech volume', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232248, 'HP:5200043', 'Abnormal speech volume', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232249, 'HP:5200043', 'Abnormal speech volume', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232250, 'HP:5200043', 'Abnormal speech volume', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232251, 'HP:5200043', 'Abnormal speech volume', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232252, 'HP:5200043', 'Abnormal speech volume', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232253, 'HP:5200043', 'Abnormal speech volume', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232254, 'HP:5200043', 'Abnormal speech volume', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232255, 'HP:5200043', 'Abnormal speech volume', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232256, 'HP:5200043', 'Abnormal speech volume', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232257, 'HP:5200043', 'Abnormal speech volume', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232258, 'HP:5200043', 'Abnormal speech volume', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232259, 'HP:5200043', 'Abnormal speech volume', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232260, 'HP:5200043', 'Abnormal speech volume', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232261, 'HP:5200043', 'Abnormal speech volume', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232262, 'HP:5200043', 'Abnormal speech volume', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232263, 'HP:5200043', 'Abnormal speech volume', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232264, 'HP:5200043', 'Abnormal speech volume', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232265, 'HP:5200043', 'Abnormal speech volume', 'MP:0003469', 'decreased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232266, 'HP:5200043', 'Abnormal speech volume', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232267, 'HP:5200043', 'Abnormal speech volume', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232268, 'HP:5200043', 'Abnormal speech volume', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232269, 'HP:5200043', 'Abnormal speech volume', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232270, 'HP:5200043', 'Abnormal speech volume', 'MP:0003480', 'increased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232271, 'HP:5200043', 'Abnormal speech volume', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232272, 'HP:5200043', 'Abnormal speech volume', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232273, 'HP:5200043', 'Abnormal speech volume', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232274, 'HP:5200043', 'Abnormal speech volume', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232275, 'HP:5200043', 'Abnormal speech volume', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232276, 'HP:5200043', 'Abnormal speech volume', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232277, 'HP:5200043', 'Abnormal speech volume', 'MP:0010149', 'abnormal synaptic dopamine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232278, 'HP:5200043', 'Abnormal speech volume', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232279, 'HP:5200043', 'Abnormal speech volume', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232280, 'HP:5200043', 'Abnormal speech volume', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232281, 'HP:5200043', 'Abnormal speech volume', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232282, 'HP:5200043', 'Abnormal speech volume', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232283, 'HP:5200043', 'Abnormal speech volume', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232284, 'HP:5200043', 'Abnormal speech volume', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232285, 'HP:5200043', 'Abnormal speech volume', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232286, 'HP:5200043', 'Abnormal speech volume', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232287, 'HP:5200043', 'Abnormal speech volume', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232288, 'HP:5200043', 'Abnormal speech volume', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232289, 'HP:5200043', 'Abnormal speech volume', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232290, 'HP:5200043', 'Abnormal speech volume', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232291, 'HP:5200043', 'Abnormal speech volume', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232292, 'HP:5200043', 'Abnormal speech volume', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232293, 'HP:5200043', 'Abnormal speech volume', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232294, 'HP:5200043', 'Abnormal speech volume', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232295, 'HP:5200043', 'Abnormal speech volume', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232296, 'HP:5200043', 'Abnormal speech volume', 'MP:0012261', 'increased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232297, 'HP:5200043', 'Abnormal speech volume', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232298, 'HP:5200043', 'Abnormal speech volume', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232299, 'HP:5200043', 'Abnormal speech volume', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232300, 'HP:5200043', 'Abnormal speech volume', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232301, 'HP:5200043', 'Abnormal speech volume', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232302, 'HP:5200043', 'Abnormal speech volume', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232303, 'HP:5200043', 'Abnormal speech volume', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232304, 'HP:5200043', 'Abnormal speech volume', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232305, 'HP:5200043', 'Abnormal speech volume', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232306, 'HP:5200043', 'Abnormal speech volume', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232307, 'HP:5200043', 'Abnormal speech volume', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232308, 'HP:5200043', 'Abnormal speech volume', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232309, 'HP:5200043', 'Abnormal speech volume', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232310, 'HP:5200043', 'Abnormal speech volume', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232311, 'HP:5200043', 'Abnormal speech volume', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232312, 'HP:5200043', 'Abnormal speech volume', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232313, 'HP:5200043', 'Abnormal speech volume', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232314, 'HP:5200043', 'Abnormal speech volume', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232315, 'HP:5200043', 'Abnormal speech volume', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232316, 'HP:5200043', 'Abnormal speech volume', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232317, 'HP:5200043', 'Abnormal speech volume', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232318, 'HP:5200043', 'Abnormal speech volume', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232319, 'HP:5200043', 'Abnormal speech volume', 'MP:0003008', 'enhanced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232320, 'HP:5200043', 'Abnormal speech volume', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232321, 'HP:5200043', 'Abnormal speech volume', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232322, 'HP:5200043', 'Abnormal speech volume', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232323, 'HP:5200043', 'Abnormal speech volume', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232324, 'HP:5200043', 'Abnormal speech volume', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232325, 'HP:5200043', 'Abnormal speech volume', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232326, 'HP:5200043', 'Abnormal speech volume', 'MP:0001496', 'audiogenic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232327, 'HP:5200043', 'Abnormal speech volume', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232328, 'HP:5200043', 'Abnormal speech volume', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232329, 'HP:5200043', 'Abnormal speech volume', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232330, 'HP:5200043', 'Abnormal speech volume', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232331, 'HP:5200043', 'Abnormal speech volume', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232332, 'HP:5200043', 'Abnormal speech volume', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232333, 'HP:5200043', 'Abnormal speech volume', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232334, 'HP:5200043', 'Abnormal speech volume', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232335, 'HP:5200043', 'Abnormal speech volume', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232336, 'HP:5200043', 'Abnormal speech volume', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232337, 'HP:5200043', 'Abnormal speech volume', 'MP:0002634', 'abnormal sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232338, 'HP:5200043', 'Abnormal speech volume', 'MP:0004835', 'abnormal miniature endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232339, 'HP:5200043', 'Abnormal speech volume', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232340, 'HP:5200043', 'Abnormal speech volume', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232341, 'HP:5200043', 'Abnormal speech volume', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232342, 'HP:5200043', 'Abnormal speech volume', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232343, 'HP:5200043', 'Abnormal speech volume', 'MP:0001475', 'reduced long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232344, 'HP:5200043', 'Abnormal speech volume', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232345, 'HP:5200043', 'Abnormal speech volume', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232346, 'HP:5200043', 'Abnormal speech volume', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232347, 'HP:5200043', 'Abnormal speech volume', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232348, 'HP:5200043', 'Abnormal speech volume', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232349, 'HP:5200043', 'Abnormal speech volume', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232350, 'HP:5200043', 'Abnormal speech volume', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232351, 'HP:5200043', 'Abnormal speech volume', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232352, 'HP:5200043', 'Abnormal speech volume', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232353, 'HP:5200043', 'Abnormal speech volume', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232354, 'HP:5200043', 'Abnormal speech volume', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232355, 'HP:5200043', 'Abnormal speech volume', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232356, 'HP:5200043', 'Abnormal speech volume', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232357, 'HP:5200043', 'Abnormal speech volume', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232358, 'HP:5200043', 'Abnormal speech volume', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232359, 'HP:5200043', 'Abnormal speech volume', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232360, 'HP:5200043', 'Abnormal speech volume', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232361, 'HP:5200043', 'Abnormal speech volume', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232362, 'HP:5200043', 'Abnormal speech volume', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232363, 'HP:5200043', 'Abnormal speech volume', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232364, 'HP:5200043', 'Abnormal speech volume', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232365, 'HP:5200043', 'Abnormal speech volume', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232366, 'HP:5200043', 'Abnormal speech volume', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232367, 'HP:5200043', 'Abnormal speech volume', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232368, 'HP:5200043', 'Abnormal speech volume', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232369, 'HP:5200043', 'Abnormal speech volume', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(232370, 'HP:5200043', 'Abnormal speech volume', 'MP:0002578', 'impaired ability to fire action potentials', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232371, 'HP:5200043', 'Abnormal speech volume', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(232372, 'HP:5200043', 'Abnormal speech volume', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
